Cognitive Auditory Evoked Potential After Cardiac Arrest: Interest of Mismatch negativiTY (CAPACITY)

August 19, 2020 updated by: Assistance Publique - Hôpitaux de Paris

Cognitive Auditory Evoked Potential After Cardiac Arrest: Interest of Mismatch negativiTY: The CAPACITY Study

Determination of vital and functional outcome in comatose survivors after cardiac arrest is principally based on the identification of predictors of non-awakening, using by clinical, biological and electrophysiological tools. In patients without presence of non-awakening predictors, it would be of interest to identify predictive criteria of awakening. The presence of mismatch negativity during the cortical auditory-evoked potential could contribute to further progress in neurological prognostication of these patients. However, at this time, its prognostic value has been insufficiently studied and the optimal time of realization remains unknown.

Study Overview

Status

Completed

Conditions

Detailed Description

We hypothesized that the presence of the mismatch negativity during the cortical auditory-evoked potential would predict a favorable outcome in comatose survivors after cardiac arrest.The main objective is to determine the capacity of the presence of the mismatch negativity during the cortical auditory-evoked potential to predict a 1-year favorable outcome in comatose survivors after cardiac arrest

The secondary objectives are:

  • To assess the capacity of the presence of the mismatch negativity during the cortical auditory-evoked potential to predict awakening during the hospitalisation stay.
  • To determine the optimal time of realization of the cortical auditory-evoked potential
  • To determine the capacity of the presence of the mismatch negativity during the cortical auditory-evoked potential to predict ICU discharge and/or hospital discharge favorable outcome in comatose survivors after cardiac arrest
  • To determine the impact of the sedations drugs during the hypothermia phase, and during the ICU stay The main judgement criterion is the 1-year CPC score (CPC 1 to 2 as a favorable outcome)

Study design : Prospective, multicentre, interventional study. Decision making to withdrawal of life support will be strictly codified according current knowledge and standardized among the participating centres. In the absence of predictors of non-awakening, care will be continued without limitation. The design of the study will focus on the determination of the capacity of the presence of the mismatch negativity during the cortical auditory-evoked potential to predict awakening. Cortical auditory-evoked potential will be performed bedside in the ICU by qualified neurophysiologists. Results of cortical auditory-evoked potential will remain blinded of bedside clinicians providing care for the patients. Awakening will be assessed bedside daily. CPC score will be evaluated at discharge of the ICU, of the hospital, at 3 months and 1 year by an independent evaluator, blinded of the results of the cortical auditory-evoked potentials.

Study Type

Interventional

Enrollment (Actual)

85

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75010
        • Lariboisière Hospital - Medical and toxicology unit
      • Versailles, France, 78150
        • Dr Stéphane LEGRIEL - Intensive Care Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults (age ≥ 18 years)
  • hospitalized in the intensive care unit in the aftermath of a intra-or extra-hospital cardiac arrest
  • alive but remaining comatose between the 2nd day and the 5th day after cardiopulmonary arrest

Exclusion Criteria:

  • moribund patients (treatment limitations or the life expectancy of the inclusion estimated at less than 1 year)
  • patient awake at day of potential inclusion
  • brain death state
  • failure to realize the cortical
  • patient whose hearing loss is known

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: 1:Mismatch negativity
Presence of the mismatch negativity during the cortical auditory-evoked potential would predict a favorable outcome in comatose survivors after cardiac arrest.
cortical auditory-evoked potentials are performed to all included patients at inclusion, at day 5 to day 10, day without sedation (up to 1 year), day of awakening

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CPC score of 1 or 2 (favorable outcome)
Time Frame: 1 year
1-year CPC score of 1 or 2 (favorable outcome)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Awakeness
Time Frame: up to 1 year
Awakeness during the hospitalisation stay
up to 1 year
Time of realization of the cortical auditory-evoked potential
Time Frame: up to 1 year
the optimal time of realization of the cortical auditory-evoked potential
up to 1 year
CPC score of 1 or 2 at ICU discharge
Time Frame: up to 1 year
the CPC score of 1 or 2 at ICU and at hospital discharge
up to 1 year
Length of mechanical ventilation, ICU stay, hospital stay and vital status at discharge
Time Frame: up to 1 year
impact of the sedations drugs during the ICU stay impact of therapeutic hypothermia
up to 1 year
CPC score of 1 or 2 at hospital discharge
Time Frame: up to 1 year
the CPC score of 1 or 2 at hospital discharge
up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephane LEGRIEL, MD, Versailles Hospital - 78150 Le Chesnay - France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2013

Primary Completion (ACTUAL)

June 1, 2018

Study Completion (ACTUAL)

June 1, 2019

Study Registration Dates

First Submitted

October 24, 2013

First Submitted That Met QC Criteria

November 4, 2013

First Posted (ESTIMATE)

November 11, 2013

Study Record Updates

Last Update Posted (ACTUAL)

August 20, 2020

Last Update Submitted That Met QC Criteria

August 19, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P091118
  • 2010-A01378-31 (OTHER: IDRCB)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on Auditory-evoked potentials

Subscribe